Rx-to-OTC Switch Forecasts USA 2010

This comprehensive report provides subscribers with objective, independent forecasts of future Rx-to-OTC switches and their expected impacts on the OTC market. This analysis provides forecasts of future switches in existing OTC categories and projections for new OTC categories. (Y406C)

TABLE OF CONTENTS
Introduction Executive Summary FutureView Switch Forecasts Comparative analysis of Rx and OTC markets Demographics of target population Incidence and prevalence of the disease/ condition Patent expirations in the class and generic threats Strategic considerations for Rx-to-OTC switch Regulatory considerations Safety issues/indications appropriate for OTC use Timing Pricing considerations Marketing issues Switch forecast Brand(s) that are likely to switch Implications for Rx and OTC markets Expected future OTC sales Forecasts of competitive responses including both branded and private-label OTCs		FutureView Forecasting Model Forecasts by therapeutic class and brand in this report are generated with Kline's FutureView Scenario Forecasting Model, which provides Kline's forecasts for future switches and allows users to change assumptions to see how various scenarios may impact future switch sales. Subscribers can see how adjustments in the assumptions behind the forecasts can bring about different outcomes.

Contact

Laura Mahecha laura.mahecha@klinegroup.com +1-973-435-3446